has been cited by the following article(s):
[1]
|
Enhanced in vitro and in vivo anticancer activity through the development of Sunitinib-Loaded nanoniosomes with controlled release and improved uptake
International Journal of Pharmaceutics,
2023
DOI:10.1016/j.ijpharm.2023.122977
|
|
|
[2]
|
Enhanced in vitro and in vivo anticancer activity through the development of Sunitinib-Loaded nanoniosomes with controlled release and improved uptake
International Journal of Pharmaceutics,
2023
DOI:10.1016/j.ijpharm.2023.122977
|
|
|